Published in Aging. Regardless of how old you are, your blood glucose levels will rise and fall through the aving. Just how much your levels rise and fall through the day will usually depend on what you eat and how Hypergllycemia energy your body burns. Some Hyperglycemia and aging people Hyperrglycemia see more frequent spikes, putting them at risk of anr diabetes.
In fact, according to the CDC, about Wondering Hypsrglycemia this happens? Hyperglycemka Hyperglycemia and aging leads Injury prevention supplements for athletes a rise Indulge in the pleasure of thirst satisfaction blood glucose levels, which in turn Blood glucose test your risk of developing things like heart disease and stroke.
Remember that aaging changes Hyperglycemia and aging way Optimal nutrient timing body metabolizes glucose, which is a contributing factor Ane. Glucose levels also fluctuate due to physiological factors that affect how your body handles carbohydrates, fats, and proteins.
Understanding Organic supplement reviews health history Hyperglcyemia risk for developing diabetes can be challenging. Your body goes Hyperglycejia many changes as Hypedglycemia age. While Hyperglycema may be expecting some of these agong an expanding waistline or gray hair, you may Hyperblycemia see others Hyperglycemia and aging higher blood glucose levels coming.
Studies have found that Blood glucose test people age, elevated Hyperg,ycemia and insulin levels are more Sugar consumption facts when evaluating Hyperglyceia glucose tolerance tests OGTT.
This is Hyperglydemia test that measures how well your body responds to Green beauty options. Glucose and insulin agong among older adults Hypergglycemia to be higher than among younger people.
These higher glucose and insulin Hyperglycemia and aging may indicate Hyperglycemia and aging your body Hyperg,ycemia utilize glucose for energy efficiently. It causes a cycle of Healthy digestion diet glucose values and more insulin production.
So what agibg do Coenzyme Q for heart disease do during these Hypergycemia glucose tests? Hyperglycrmia of the first things agiing medical professional will ating as part Vitamins for joint health this test, is take a blood sample Hyperglyemia check your fasting glucose levels.
You will then drink ad sugary agijg that contains 75 Body water percentage tracking of glucose. After around two hours, the medical professional tests your blood glucose again to see how much it spikes.
It's a fairly common test, doctors even use a modified version of it during pregnancy to check for gestational diabetes. It's also relatively simple and reliable, but it does involve giving people an amount and concentration of sugar that they would likely never consume on their own.
Although older adults may have higher glucose levels after the glucose test, the rate of insulin production during the first hour is lower than among younger adults. This means as you age, your body is unable to produce insulin as efficiently when consuming a large glucose load.
A clinical research program, called the Baltimore Longitudinal Study of Agingbegan in to study the effects of aging over time. Healthy people of various ages join the study, which analyzes them over several follow-up visits throughout their lifetime.
As you age, glucose tolerance can progress from normal glucose tolerance to impaired fasting glucose, then to impaired glucose tolerance, and finally to type 2 diabetes. However, researchers are still studying the reasons for the progression.
As part of this study, subjects underwent oral glucose tolerance tests every two years. Researchers were testing how the glucose levels among people starting with normal glucose tolerance would change over time. This gives you an idea of how your levels can change over time, but what can you do about it?
By now, you know that as you age, your glucose levels will change. While research is ongoing here as well, some risk factors may contribute to changes in glucose metabolism as you grow older. Aging kidneys may not be able to filter glucose from your blood as well as they used to, and high glucose levels in the bloodstream can have adverse effects on your long-term health.
Here are some other factors that may affect your blood glucose levels:. The oral glucose tolerance test we mentioned above clarifies how differently your body can respond to the same things as you age.
But, can you change it all with some dietary modifications? The study compared the results of older adults with younger adults who consumed identical diets. According to the results, eating a low-carbohydrate diet can help with some insulin sensitivity.
Even though older adults saw impaired insulin secretion rates following the glucose challenge compared to younger adults, eating a lower-carb diet may be a helpful intervention.
Of course, everyone is different, so these results are not a hard-and-fast rule. Regardless of how your body responds, knowing what to expect and how to manage it is the best health decision you can make.
Your blood sugar levels can significantly impact how your body feels and functions. When you join the Nutrisense CGM programour team of credentialed dietitians and nutritionists are available for additional support and guidance to help you reach your goals.
Ready to take the first step? Start with our quiz to see how Nutrisense can support your health. How It Works Nutritionists Journal. What Is A CGM? Get Started. Promo code SPRING will be automatically applied at checkout!
The Effect of Aging on Your Blood Glucose Levels. Team Nutrisense. Share on Twitter. Share on Facebook. Share via Email. Reviewed by. Kara Collier, RDN, LDN, CNSC. How Your Body Handles Glucose as You Age. Related Article. Read More. Engage with Your Blood Glucose Levels with Nutrisense Your blood sugar levels can significantly impact how your body feels and functions.
Take Our Quiz. Reviewed by: Kara Collier, RDN, LDN, CNSC. Learn more about Kara. On this page. Example H2. Aging and Balance: Why Older People Experience Loss of Balance Aging. Explore topics. Women's Health. Mental Health. CGMs and Sensors. Nutritionist Recommended. Weight Loss. Food Experimentation.
Metabolic Health.
: Hyperglycemia and aging| Does Aging Change Blood Glucose Levels? | Sinclair AJ, Abdelhafiz AH, Rodríguez-Mañas L. Frailty and sarcopenia—newly emerging and high impact complications of diabetes. J Diabetes Complications. Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. Hyperglycemia predicts persistently lower muscle strength with aging. Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean Longitudinal study on health and aging. Diabetes Metab J. Lee S, Lee S, Harada K, Bae S, Makizako H, Doi T, et al. Relationship between chronic kidney disease with diabetes or hypertension and frailty in community-dwelling Japanese older adults. Geriatr Gerontol Int. Castrejón-Pérez RC, Gutiérrez-Robledo LM, Cesari M, Pérez-Zepeda MU. Diabetes mellitus, hypertension and frailty: a population-based, cross-sectional study of Mexican older adults. Hasan SS, Mamun AA, Clavarino AM, Kairuz T. Incidence and risk of depression associated with diabetes in adults: evidence from longitudinal studies. Community Ment Health J. Sinclair AJ, Abdelhafiz AH. Challenges and strategies for diabetes management in community-living older adults. Diabetes Spectr. Lohman M, Dumenci L, Mezuk B. Depression and frailty in late life: evidence for a common vulnerability. J Gerontol B Psychol Sci Soc Sci. Soysal P, Veronese N, Thompson T, Kahl KG, Fernandes BS, Prina AM, et al. Relationship between depression and frailty in older adults: a systematic review and meta-analysis. Ageing Res Rev. Godin J, Armstrong JJ, Rockwood K, Andrew MK. Dynamics of frailty and cognition after age why it matters that cognitive decline is mostly seen in old age. J Alzheimers Dis. Liu YC, Meguro K, Nakamura K, Akanuma K, Nakatsuka M, Seki T, et al. Depression and dementia in old-old population: history of depression may be associated with dementia onset. The Tome Project. Front Aging Neurosci. Aichele S, Ghisletta P. Memory deficits precede increases in depressive symptoms in later adulthood. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol. Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol. Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. Dhar AK, Barton DA. Depression and the link with cardiovascular disease. Front Psychiatry. Feil DG, Zhu CW, Sultzer DL. The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes. J Behav Med. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. Ligthelm RJ, Kaiser M, Vora J, Yale JF. Insulin use in elderly adults: risk of hypoglycemia and strategies for care. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. Adults O. Standards of medical care in diabetes Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am. Miller CK, Edwards L, Kissling G, Sanville L. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. Prev Med. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Wedick NM, Barrett-Connor E, Knoke JD, Wingard DL. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. Haas LB. Special considerations for older adults with diabetes residing in skilled nursing facilities. Morey MC, Pieper CF, Crowley GM, Sullivan RJ, Puglisi CM. Exercise adherence and year mortality in chronically ill older adults. Karani R, McLaughlin MA, Cassel CK. Exercise in the healthy older adult. Am J Geriatr Cardiol. Inzucchi SE. Is it time to change the type 2 diabetes treatment paradigm? metformin should remain the foundation therapy for type 2 diabetes. Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. Natali A, Ferrannini E. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Mulherin AJ, Oh AH, Kim H, Grieco A, Lauffer LM, Brubaker PL. Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell. Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Fullerton MD, Galic S, Marcinko K, Sikkema S, Pulinilkunnil T, Chen ZP, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes UKPDS UK Prospective Diabetes Study UKPDS Group. Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Kooy A, de Jager J, Lehert P, Bets D, Wulffelé MG, Donker AJ, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med. Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, et al. Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. Qaseem A, Barry MJ, Humphrey LL, Forciea MA. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the American College of Physicians. Ann Intern Med. Lv W, Wang X, Xu Q, Lu W. Mechanisms and characteristics of sulfonylureas and glinides. Curr Top Med Chem. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. Rosenkranz B, Profozic V, Metelko Z, Mrzljak V, Lange C, Malerczyk V. Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment. Dills DG, Schneider J. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Horm Metab Res. Horani MH, Mooradian AD. Management of obesity in the elderly: special considerations. Treat Endocrinol. Schwartz TB, Meinert CL. The UGDP controversy: thirty-four years of contentious ambiguity laid to rest. Perspect Biol Med. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, et al. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin TOSCA. IT : a randomised, multicentre trial. Lancet Diabetes Endocrinol. Balfour JA, Faulds D. Drugs Aging. Johansen OE, Birkeland KI. Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review. Am J Cardiovasc Drugs. Schwarz SL, Gerich JE, Marcellari A, Jean-Louis L, Purkayastha D, Baron MA. Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes. Diabetes Obes Metab. Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, et al. Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: a randomized controlled trial of repaglinide vs sulfonylurea. J Diabetes Investig. Mooradian AD, Chehade J, Thurman JE. The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes RECORD : a multicentre, randomised, open-label trial. Damluji AA, Cohen ER, Moscucci M, Myerburg RJ, Cohen MG, Brooks MM, et al. Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: insights from BARI-2D trial. Int J Cardiol. Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, et al. Pioglitazone after ischemic stroke or transient ischemic attack. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study PROspective pioglitAzone Clinical Trial In macroVascular Events : a randomised controlled trial. Aubert RE, Herrera V, Chen W, Haffner SM, Pendergrass M. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes. Hedrington MS, Davis SN. Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes. Expert Opin Pharmacother. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. Coleman RL, Scott CAB, Lang Z, Bethel MA, Tuomilehto J, Holman RR. Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes. Cardiovasc Diabetol. Josse RG, Chiasson JL, Ryan EA, Lau DC, Ross SA, Yale JF, et al. Acarbose in the treatment of elderly patients with type 2 diabetes. Mooradian AD, Albert SG, Wittry S, Chehade J, Kim J, Bellrichard B. Dose-response profile of acarbose in older subjects with type 2 diabetes. Am J Med Sci. Gandhi GY, Mooradian AD. Clinical considerations for insulin therapy in older adults with type 1 diabetes. Article PubMed Google Scholar. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, Sinclair AJ. Hypoglycemia in older people—a less well recognized risk factor for frailty. Aging Dis. Munshi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. Simplification of insulin regimen in older adults and risk of hypoglycemia. Leung E, Wongrakpanich S, Munshi MN. Diabetes management in the elderly. Munshi MN, Pandya N, Umpierrez GE, DiGenio A, Zhou R, Riddle MC. Contributions of basal and prandial hyperglycemia to total hyperglycemia in older and younger adults with type 2 diabetes mellitus. Pasquel FJ, Powell W, Peng L, Johnson TM, Sadeghi-Yarandi S, Newton C, et al. A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities. BMJ Open Diabetes Res Care. Oiknine R, Bernbaum M, Mooradian AD. A critical appraisal of the role of insulin analogues in the management of diabetes mellitus. Janka HU, Plewe G, Busch K. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus. Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes OpT2mise : a randomised open-label controlled trial. Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Stephens EA, Heffner J. Evaluating older patients with diabetes for insulin pump therapy. Diabetes Technol Ther. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Pham H, Marathe CS, Phillips LK, Trahair LG, Hatzinikolas S, Huynh L, et al. Longitudinal changes in fasting and glucose-stimulated GLP-1 and GIP in healthy older subjects. Neumiller JJ. Incretin-based therapies. Med Clin North Am. Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. Thomsen RW, Pedersen L, Møller N, Kahlert J, Beck-Nielsen H, Sørensen HT. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study. Pencek R, Blickensderfer A, Li Y, Brunell SC, Anderson PW. Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index. Postgrad Med. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes REWIND : a double-blind, randomised placebo-controlled trial. Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. Andrikou E, Tsioufis C, Andrikou I, Leontsinis I, Tousoulis D, Papanas N. Barzilay JI, Cotsonis GA, Walston J, et al. Diabetes care. Rooney MR, Rawlings AM, Pankow JS, et al. Risk of Progression to Diabetes Among Older Adults With Prediabetes. JAMA Internal Medicine. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. Berdichevsky A, Guarente L, Bose A. Journal of Biological Chemistry. Yi S-W, Park S, Lee Y-h, Park H-J, Balkau B, Yi J-J. Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study. Sci Rep. How much physical activity do adults need? Accessed July 4, Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose uptake — regulation and implications for glycaemic control. Nature Reviews Endocrinology. Baptista LC, Machado-Rodrigues AM, Martins RA. Back to basics with active lifestyles: exercise is more effective than metformin to reduce cardiovascular risk in older adults with type 2 diabetes. Biol Sport. Dec ;35 4 Mitri J, Pittas AG. Vitamin D and Diabetes. Endocrinology and Metabolism Clinics of North America. The National Academies of Sciences E, and Medicine,. IOM Report Sets New Dietary Intake Levels for Calcium and Vitamin D To Maintain Health and Avoid Risks Associated With Excess. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. Donga E, van Dijk M, van Dijk JG, et al. A Single Night of Partial Sleep Deprivation Induces Insulin Resistance in Multiple Metabolic Pathways in Healthy Subjects. Leann Poston, MD, is a licensed physician in Ohio who holds an MBA and an M. She is a medical writer and educator who researches and writes about medicine, education, and healthcare administration. Please note: The Signos team is committed to sharing insightful and actionable health articles that are backed by scientific research, supported by expert reviews, and vetted by experienced health editors. The Signos blog is not intended to diagnose, treat, cure or prevent any disease. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider. Read more about our editorial process and content philosophy here. Take control of your health with data-backed insights that inspire sustainable transformation. Your body is speaking; now you can listen. Interested in learning more about metabolic health and weight management? Copyright © Signos Inc. This product is used to measure and analyze glucose readings for weight loss purposes only. It is not intended to diagnose, cure, mitigate, treat, or prevent pre-diabetes, diabetes, or any disease or condition, nor is it intended to affect the structure or any function of the body. Privacy Policy. How It Works. View Plans. Home How It Works FAQs Blog View Plans. Does Aging Change Blood Glucose Levels? Reviewed by Leann Poston, MD, MBA, M. Updated by. Science-based and reviewed. Metabolic Health. Glucose Metabolism. Table of contents Example H2. Example H3. Low blood sugar can increase the risk of: 8 Falling Confusion Cardiovascular events such as heart attacks and chest pain Cognitive function declines Fatigue Dizziness For this reason, older adults, especially people with medical problems, have slightly wider target ranges for blood glucose to reduce the risk of hypoglycemia. However, there are other age-related changes in muscles that also contribute to insulin resistance, including: An increase in mitochondrial dysfunction —makes it more difficult to convert macronutrients to energy. A decrease in mitochondrial number —there is a positive correlation between the number of skeletal muscle mitochondria and insulin sensitivity. Increased inflammation —increases insulin resistance. An increase in fat deposits —As lipids fats increase in muscle cells, they affect enzymes involved in the insulin signaling pathway and increase inflammation. Exposure to more oxidative stress —makes metabolism less efficient and increases insulin resistance. Decreased ability to get rid of nonfunctional or poorly functioning muscle cells. An overactive renin-angiotensin system —increases inflammation and oxidative stress. Get more information about weight loss, glucose monitors, and living a healthier life. Topics discussed in this article: Metabolic Health. References 1. html 5. html 6. html 7. i Freeman AM, Pennings N. Insulin Resistance. StatPearls Publishing Copyright © , StatPearls Publishing LLC. htm About the author Leann Poston, MD, is a licensed physician in Ohio who holds an MBA and an M. View Author Bio. Glucose Latest articles. Beginner's Guide to Glucose Sabrina Tillman. What Are Normal Blood Sugar Levels for Non-Diabetic People? Caitlin Beale, MS, RDN. Insulin Resistance and Prediabetes: Symptoms, Risk Factors, and What You Can Do Leann Poston, MD, MBA, M. How to Improve Impaired Fasting Glucose Caitlin Beale, MS, RDN. What Factors Affect Blood Sugar Levels? Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk. Circ Res. St-Onge MP, Gallagher D. Body composition changes with aging:the cause or the result of alterations in metabolic rate andmacronutrient oxidation? Nutrition —5. Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, et al. Fat tissue, aging, and cellular senescence. Aging Cell — Mooradian AD. Evidence-based management of diabetes in older adults. Drugs Aging — Huang ES. Management of diabetes mellitus in older people with comorbidities. BMJ i Kotsani M, Chatziadamidou T, Economides D, Benetos A. Higher prevalence and earlier appearance of geriatric phenotypes in old adults with type 2 diabetes mellitus. Diabetes Res Clin Pract. Abdelhafiz AH, Sinclair AJ. Management of type 2 diabetes in older people. Diabetes Ther. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia —9. Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interv Aging —9. Bruce DG, Nelson ME, Mace JL, Davis WA, Davis TM, Starkstein SE. Apathy in older patients with type 2 diabetes. Am J Geriatr Psychiatry — Park M, Reynolds CF. Depression among older adults with diabetes mellitus. Clin Geriatr Med. American Diabetes Association. Older adults: standards of medical care in diabetes Diabetes Care S— Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient's mobility and independence. Acta Diabetol. Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 diabetes and osteoporosis: a guide to optimal management. J Clin Endocrinol Metab. Dhindsa S, Ghanim H, Batra M, Dandona P. Hypogonadotropic hypogonadism in men with diabesity. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of hip fractures in older individuals with diabetes: a population-based study. Rochira V, Antonio L, Vanderschueren D. EAA clinical guideline on management of bone health in the andrological outpatient clinic. Andrology — Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. Wallander M, Axelsson KF, Nilsson AG, Lundh D, Lorentzon M. Type 2 diabetes and risk of hip fractures and non-skeletal fall injuries in the elderly: a study from the fractures and fall injuries in the elderly cohort FRAILCO. J Bone Miner Res. Vogel T, Brechat PH, Leprêtre PM, Kaltenbach G, Berthel M, Lonsdorfer J. Health benefits of physical activity in older patients: a review. Int J Clin Pract — Tepper S, Alter Sivashensky A, Rivkah Shahar D, Geva D, Cukierman-Yaffe T. The association between mediterranean diet and the risk of falls and physical function indices in older type 2 diabetic people varies by age. Nutrients American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus, Moreno G, Mangione CM, Kimbro L, Vaisberg E. Guidelines abstracted from the American geriatrics society guidelines for improving the care of older adults with diabetes mellitus: update. Hsu A, Conell-Price J, Stijacic Cenzer I, Eng C, Huang AJ, Rice-Trumble K, et al. Predictors of urinary incontinence in community-dwelling frail older adults with diabetes mellitus in a cross-sectional study. BMC Geriatr. Hart HE, Rutten GE, Bontje KN, Vos RC. Overtreatment of older patients with type 2 diabetes mellitus in primary care. Diabetes Obes Metab. Deintensification of hypoglycaemic medications-use of a systematic review approach to highlight safety concerns in older people with type 2 diabetes. Diabetes Complicat. Alwhaibi M, Balkhi B, Alhawassi TM, Alkofide H, Alduhaim N, Alabdulali R, et al. Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open 8:e Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Munshi MN. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care —7. Majumdar SR, Hemmelgarn BR, Lin M, McBrien K, Manns BJ, Tonelli M. Hypoglycemia associated with hospitalization and adverse events in older people: population-based cohort study. Kagansky N, Levy S, Rimon E, Cojocaru L, Fridman A, Ozer Z, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. Migdal A, Yarandi SS, Smiley D, Umpierrez GE. Update on diabetes in the elderly and in nursing home residents. J Am Med Dir Assoc. Huang CC, Weng SF, Tsai KT, Chen PJ, Lin HJ, Wang JJ, et al. Long-term mortality risk after hyperglycemic crisis episodes in geriatric patients with diabetes: a national population-based cohort study. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. Palta P, Huang ES, Kalyani RR, Golden SH, Yeh H-C. Hemoglobin A1C and mortality in older adults with and without diabetes: results from the National Health and Nutrition Examination Surveys — Abbasi J. For patients with type 2 diabetes, what's the best target hemoglobin A1C? JAMA —9. Lee SJ, Eng C. Goals of glycemic control in frail older patients with diabetes. JAMA —1. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm - executive summary. Endocr Pract. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA, et al. Hemoglobin A1c Targets for glycemic control with pharmacologic therapy for non-pregnant adults with type 2 diabetes mellitus: a guidance statement update from the American college of physicians. Ann Intern Med. Giugliano D, Maiorino MI, Bellastella G, Esposito K. Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialog. J Endocrinol Invest. McLaren LA, Quinn TJ, McKay GA. Diabetes control in older people. BMJ f Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in type 2 diabetes, a consensus report by the American Diabetes Association ADA and the European association for the study of diabetes EASD. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Wilcox R, Kupfer S, Erdmann E. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone clinical trial in macro vascular events PROactive Am Heart J. Schneider CA, Ferrannini E, Defronzo R, Schernthaner G, Yates J, Erdmann E. Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol. Viscoli CM, Inzucchi SE, Young LH, Insogna KL, Conwit R, Furie KL, et al. Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial. Lewis JD, Habel LA, Quesenberry CP, Strom BL, Peng T, Hedderson MM, et al. Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes. Yakaryılmaz FD, Öztürk ZA. Treatment of type 2 diabetes mellitus in the elderly. World J Diabetes — Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, et al. Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: a randomized controlled trial of repaglinide vs. J Diabetes Investig. Inzucchi SE, Nauck MA, Hehnke U, Woerle HJ, von Eynatten M, Henry RR. Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes. Barnett AH, Huisman H, Jones R, von Eynatten M, Patel S, Woerle HJ. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo controlled trial. Esposito K, Chiodini P, Maiorino MI, Capuano A, Cozzolino D, Petrizzo M, et al. A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 patients. BMJ Open 5:e Rizzo MR, Barbieri M, Fava I, Desiderio M, Coppola C, Marfella R, et al. Sarcopenia in elderly diabetic patients: role of dipeptidyl peptidase 4 inhibitors. Nauck MA, Meier JJ, Cavender MA, Abd El Aziz M, Drucker DJ. Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Circulation — White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, et al. Effect of linagliptin vs. placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk-The Carmelina Randomized clinical trial. Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, et al. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Zannad F, Cannon CP, Cushman WC, Bakris GL, Menon V, Perez AT, et al. |
| How Is Diabetes Diagnosed? | Please note: The Signos team is committed to sharing insightful and actionable health articles that are backed by scientific research, supported by expert reviews, and vetted by experienced health editors. Metformin, a biguanide, is the first-line oral medication for hyperglycemia for older adults Genome-wide association studies have consistently found that p16 INK4a , a cyclin-dependent kinase inhibitor CDKI , encoded by the Cdkn2a locus, is associated with type 2 diabetes risks 6. Apoptosis in myocardial ischemia-reperfusion. Assar ME, Laosa O, Rodríguez ML. |
| REVIEW article | Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with Aging. Endocrinol Metab Clin North Am. Jun ;42 2 Centers for Disease Control and Prevention. By the Numbers: Diabetes in America. Accessed July 3rd, Diabetes Testing. Accessed July 3, Take the Test - Prediabetes diabetes. Dubowitz N, Xue W, Long Q, et al. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity. Diabet Med. Aug ;31 8 Leung E, Wongrakpanich S, Munshi MN. Diabetes Management in the Elderly. Diabetes Spectrum. Committee ADAPP. Glycemic Targets: Standards of Medical Care in Diabetes— Diabetes Care. Pani LN, Korenda L, Meigs JB, et al. Effect of Aging on A1C Levels in Individuals Without Diabetes. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R. Age as Independent Determinant of Glucose Tolerance. Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin Sensitivity, Insulin Secretion, and Abdominal Fat: The Insulin Resistance Atherosclerosis Study IRAS Family Study. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. Govers E, Slof E, Verkoelen H, Hoor-Aukema NM. Guideline for the Management of Insulin Resistance. vol 1. Lee CC, Glickman SG, Dengel DR, Brown MD, Supiano MA. Abdominal Adiposity Assessed by Dual Energy X-Ray Absorptiometry Provides a Sex-Independent Predictor of Insulin Sensitivity in Older Adults. The Journals of Gerontology: Series A. Solerte SB, Gazzaruso C, Bonacasa R, et al. Nutritional Supplements with Oral Amino Acid Mixtures Increases Whole-Body Lean Mass and Insulin Sensitivity in Elderly Subjects with Sarcopenia. The American Journal of Cardiology. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. May 16 ; Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest. Barzilay JI, Cotsonis GA, Walston J, et al. Diabetes care. Rooney MR, Rawlings AM, Pankow JS, et al. Risk of Progression to Diabetes Among Older Adults With Prediabetes. JAMA Internal Medicine. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. Berdichevsky A, Guarente L, Bose A. Journal of Biological Chemistry. Yi S-W, Park S, Lee Y-h, Park H-J, Balkau B, Yi J-J. Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study. Sci Rep. How much physical activity do adults need? Accessed July 4, Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose uptake — regulation and implications for glycaemic control. Nature Reviews Endocrinology. Baptista LC, Machado-Rodrigues AM, Martins RA. Back to basics with active lifestyles: exercise is more effective than metformin to reduce cardiovascular risk in older adults with type 2 diabetes. Biol Sport. Dec ;35 4 Mitri J, Pittas AG. Vitamin D and Diabetes. Endocrinology and Metabolism Clinics of North America. The National Academies of Sciences E, and Medicine,. IOM Report Sets New Dietary Intake Levels for Calcium and Vitamin D To Maintain Health and Avoid Risks Associated With Excess. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. Donga E, van Dijk M, van Dijk JG, et al. A Single Night of Partial Sleep Deprivation Induces Insulin Resistance in Multiple Metabolic Pathways in Healthy Subjects. Leann Poston, MD, is a licensed physician in Ohio who holds an MBA and an M. She is a medical writer and educator who researches and writes about medicine, education, and healthcare administration. Please note: The Signos team is committed to sharing insightful and actionable health articles that are backed by scientific research, supported by expert reviews, and vetted by experienced health editors. The Signos blog is not intended to diagnose, treat, cure or prevent any disease. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider. Read more about our editorial process and content philosophy here. Take control of your health with data-backed insights that inspire sustainable transformation. Your body is speaking; now you can listen. Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. Am J Geriatr Pharmacother. Neuwahl SJ, Honeycutt AA, Poehler DC, Shrestha SS, Zhang P, Hoerger TJ. Diabetes-attributable nursing home costs for each US state. Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, to Thomson FJ, Masson EA, Leeming JT, Boulton AJ. Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing. Dorner B, Friedrich EK, Posthauer ME. Position of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. J Am Diet Assoc. Munshi MN, Florez H, Huang ES, Kalyani RR, Mupanomunda M, Pandya N, et al. Management of diabetes in long-term care and skilled nursing facilities: a position statement of the american diabetes association. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Pandya N, Thompson S, Sambamoorthi U. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. Pauly L, Stehle P, Volkert D. Nutritional situation of elderly nursing home residents. Z Gerontol Geriatr. Mooradian AD, Chehade JM. Diabetes mellitus in older adults. Am J Ther. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes ACCORD MIND : a randomised open-label substudy. Lancet Neurol. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, et al. Long-term effect of diabetes and its treatment on cognitive function. Download references. Division of Endocrinology, Department of Medicine, University of Florida College of Medicine-Jacksonville, 8th Street, LRC 2nd Floor, Jacksonville, FL, , USA. You can also search for this author in PubMed Google Scholar. Correspondence to Gunjan Y. No sources of funding were used to conduct this review or prepare this manuscript. No writing assistance was utilized in the production of this manuscript. Gunjan Y. Gandhi and Arshag D. Mooradian have no conflicts of interest that are directly relevant to the contents of this article. GYG: Review of the literature, interpretation of data, preparation of the manuscript, and critical revision for intellectual content. ADM: Article concept and design, interpretation of data, and critical revision of the manuscript for intellectual content. Reprints and permissions. Gandhi, G. Management of Hyperglycemia in Older Adults with Type 2 Diabetes. Drugs Aging 39 , 39—58 Download citation. Accepted : 21 November Published : 18 December Issue Date : January Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Abstract The increasing incidence of type 2 diabetes in the general population as well as enhanced life expectancy has resulted in a rapid rise in the prevalence of diabetes in the older population. Access this article Log in via an institution. References National diabetes statistics report PubMed Google Scholar Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. PubMed PubMed Central Google Scholar Diagnosis and classification of diabetes mellitus. Google Scholar Lee PG, Halter JB. PubMed Google Scholar Mordarska K, Godziejewska-Zawada M. PubMed PubMed Central Google Scholar Barbieri M, Rizzo MR, Manzella D, Grella R, Ragno E, Carbonella M, et al. CAS PubMed Google Scholar Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, et al. CAS PubMed Google Scholar Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, et al. CAS PubMed Google Scholar Giddings SJ, Carnaghi LR, Mooradian AD. CAS PubMed Google Scholar McLarty DG, Swai AB, Kitange HM, Masuki G, Mtinangi BL, Kilima PM, et al. CAS PubMed Google Scholar DeFronzo RA. CAS PubMed PubMed Central Google Scholar Weinger K, Beverly EA, Smaldone A. PubMed PubMed Central Google Scholar American Diabetes Association. PubMed Google Scholar LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, et al. PubMed PubMed Central Google Scholar Wong CW, Lee JS, Tam KF, Hung HF, So WY, Shum CK, et al. CAS PubMed Google Scholar Blaum C, Cigolle CT, Boyd C, Wolff JL, Tian Z, Langa KM, et al. PubMed PubMed Central Google Scholar Applegate WB, Blass JP, Williams TF. CAS PubMed Google Scholar Assar ME, Laosa O, Rodríguez ML. PubMed Google Scholar Morley JE, Cao L. PubMed PubMed Central Google Scholar Munshi M, Grande L, Hayes M, Ayres D, Suhl E, Capelson R, et al. PubMed Google Scholar Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, et al. PubMed PubMed Central Google Scholar Punthakee Z, Miller ME, Launer LJ, Williamson JD, Lazar RM, Cukierman-Yaffee T, et al. PubMed PubMed Central Google Scholar de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, et al. PubMed Google Scholar Sinclair AJ, Abdelhafiz AH, Rodríguez-Mañas L. PubMed Google Scholar Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. PubMed Google Scholar Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. PubMed PubMed Central Google Scholar Lee S, Lee S, Harada K, Bae S, Makizako H, Doi T, et al. PubMed Google Scholar Castrejón-Pérez RC, Gutiérrez-Robledo LM, Cesari M, Pérez-Zepeda MU. PubMed Google Scholar Hasan SS, Mamun AA, Clavarino AM, Kairuz T. PubMed Google Scholar Sinclair AJ, Abdelhafiz AH. PubMed PubMed Central Google Scholar Lohman M, Dumenci L, Mezuk B. PubMed Google Scholar Soysal P, Veronese N, Thompson T, Kahl KG, Fernandes BS, Prina AM, et al. PubMed Google Scholar Godin J, Armstrong JJ, Rockwood K, Andrew MK. PubMed Google Scholar Liu YC, Meguro K, Nakamura K, Akanuma K, Nakatsuka M, Seki T, et al. PubMed PubMed Central Google Scholar Aichele S, Ghisletta P. PubMed Google Scholar Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. PubMed Google Scholar Sakuma K, Yamaguchi A. PubMed PubMed Central Google Scholar Dichgans M, Leys D. CAS PubMed Google Scholar Dhar AK, Barton DA. PubMed PubMed Central Google Scholar Feil DG, Zhu CW, Sultzer DL. PubMed Google Scholar Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. CAS PubMed Google Scholar Ligthelm RJ, Kaiser M, Vora J, Yale JF. PubMed Google Scholar Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. CAS PubMed Google Scholar Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, et al. PubMed Google Scholar Adults O. Google Scholar Kalyani RR, Egan JM. CAS PubMed PubMed Central Google Scholar Miller CK, Edwards L, Kissling G, Sanville L. PubMed Google Scholar Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. CAS PubMed Google Scholar Wedick NM, Barrett-Connor E, Knoke JD, Wingard DL. PubMed Google Scholar Haas LB. PubMed PubMed Central Google Scholar Morey MC, Pieper CF, Crowley GM, Sullivan RJ, Puglisi CM. PubMed Google Scholar Karani R, McLaughlin MA, Cassel CK. CAS PubMed Google Scholar Inzucchi SE. PubMed Google Scholar Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. CAS PubMed Google Scholar Natali A, Ferrannini E. CAS PubMed Google Scholar Mulherin AJ, Oh AH, Kim H, Grieco A, Lauffer LM, Brubaker PL. CAS PubMed Google Scholar Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ. CAS PubMed PubMed Central Google Scholar Fullerton MD, Galic S, Marcinko K, Sikkema S, Pulinilkunnil T, Chen ZP, et al. CAS PubMed PubMed Central Google Scholar Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes UKPDS CAS PubMed PubMed Central Google Scholar Kooy A, de Jager J, Lehert P, Bets D, Wulffelé MG, Donker AJ, et al. CAS PubMed Google Scholar Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, et al. PubMed PubMed Central Google Scholar Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. CAS PubMed PubMed Central Google Scholar Qaseem A, Barry MJ, Humphrey LL, Forciea MA. PubMed Google Scholar Lv W, Wang X, Xu Q, Lu W. CAS PubMed Google Scholar Shorr RI, Ray WA, Daugherty JR, Griffin MR. CAS PubMed Google Scholar Rosenkranz B, Profozic V, Metelko Z, Mrzljak V, Lange C, Malerczyk V. CAS PubMed Google Scholar Dills DG, Schneider J. CAS PubMed Google Scholar Horani MH, Mooradian AD. CAS PubMed Google Scholar Schwartz TB, Meinert CL. PubMed Google Scholar Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS CAS PubMed Google Scholar Johansen OE, Birkeland KI. CAS PubMed Google Scholar Schwarz SL, Gerich JE, Marcellari A, Jean-Louis L, Purkayastha D, Baron MA. CAS PubMed Google Scholar Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, et al. CAS PubMed Google Scholar Mooradian AD, Chehade J, Thurman JE. PubMed Google Scholar Nissen SE, Wolski K. CAS PubMed Google Scholar Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, et al. CAS PubMed Google Scholar Damluji AA, Cohen ER, Moscucci M, Myerburg RJ, Cohen MG, Brooks MM, et al. Google Scholar Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, et al. CAS PubMed PubMed Central Google Scholar Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. CAS PubMed Google Scholar Aubert RE, Herrera V, Chen W, Haffner SM, Pendergrass M. CAS PubMed Google Scholar Hedrington MS, Davis SN. PubMed Google Scholar Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. CAS PubMed Google Scholar Coleman RL, Scott CAB, Lang Z, Bethel MA, Tuomilehto J, Holman RR. PubMed PubMed Central Google Scholar Josse RG, Chiasson JL, Ryan EA, Lau DC, Ross SA, Yale JF, et al. CAS PubMed Google Scholar Mooradian AD, Albert SG, Wittry S, Chehade J, Kim J, Bellrichard B. CAS PubMed Google Scholar Gandhi GY, Mooradian AD. Article PubMed Google Scholar Zammitt NN, Frier BM. PubMed Google Scholar Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, Sinclair AJ. PubMed PubMed Central Google Scholar Munshi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. PubMed Google Scholar Leung E, Wongrakpanich S, Munshi MN. PubMed PubMed Central Google Scholar Munshi MN, Pandya N, Umpierrez GE, DiGenio A, Zhou R, Riddle MC. PubMed Google Scholar Pasquel FJ, Powell W, Peng L, Johnson TM, Sadeghi-Yarandi S, Newton C, et al. PubMed PubMed Central Google Scholar Oiknine R, Bernbaum M, Mooradian AD. CAS PubMed Google Scholar Janka HU, Plewe G, Busch K. PubMed Google Scholar Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, et al. CAS PubMed Google Scholar Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, et al. CAS PubMed Google Scholar Stephens EA, Heffner J. PubMed Google Scholar Drucker DJ, Nauck MA. CAS PubMed Google Scholar Pham H, Marathe CS, Phillips LK, Trahair LG, Hatzinikolas S, Huynh L, et al. PubMed Google Scholar Neumiller JJ. PubMed Google Scholar Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, et al. PubMed PubMed Central Google Scholar Thomsen RW, Pedersen L, Møller N, Kahlert J, Beck-Nielsen H, Sørensen HT. CAS PubMed Google Scholar Pencek R, Blickensderfer A, Li Y, Brunell SC, Anderson PW. PubMed Google Scholar Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. CAS PubMed PubMed Central Google Scholar Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. CAS PubMed Google Scholar Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. CAS PubMed Google Scholar Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, et al. CAS PubMed Google Scholar Andrikou E, Tsioufis C, Andrikou I, Leontsinis I, Tousoulis D, Papanas N. PubMed Google Scholar Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, et al. CAS PubMed Google Scholar Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al. CAS PubMed Google Scholar Saw M, Wong VW, Ho IV, Liew G. Google Scholar Cowart K. PubMed Google Scholar Amori RE, Lau J, Pittas AG. CAS PubMed Google Scholar Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, et al. CAS PubMed Google Scholar He YL, Sabo R, Campestrini J, Wang Y, Riviere GJ, Nielsen JC, et al. CAS PubMed Google Scholar Bae JH, Kim S, Park EG, Kim SG, Hahn S, Kim NH. CAS PubMed PubMed Central Google Scholar Li L, Li S, Deng K, Liu J, Vandvik PO, Zhao P, et al. PubMed PubMed Central Google Scholar Mamza J, Marlin C, Wang C, Chokkalingam K, Idris I. CAS PubMed Google Scholar Makrilakis K. CAS PubMed Central Google Scholar Gilbert MP, Pratley RE. PubMed PubMed Central Google Scholar Fioretto P, Zambon A, Rossato M, Busetto L, Vettor R. CAS PubMed Google Scholar Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, Bekiari E, et al. PubMed Google Scholar Häring HU, Merker L, Seewaldt-Becker E, Weimer M, Meinicke T, Woerle HJ, et al. PubMed PubMed Central Google Scholar Ueda P, Svanström H, Melbye M, Eliasson B, Svensson AM, Franzén S, et al. PubMed PubMed Central Google Scholar Matthaei S, Bowering K, Rohwedder K, Grohl A, Parikh S. CAS PubMed Google Scholar Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al. PubMed Google Scholar Ingelfinger JR, Rosen CJ. PubMed Google Scholar Jardiance FDA approval history. CAS PubMed Google Scholar Liu J, Li L, Li S, Jia P, Deng K, Chen W, et al. PubMed PubMed Central Google Scholar Lega IC, Bronskill SE, Campitelli MA, Guan J, Stall NM, Lam K, et al. CAS PubMed Google Scholar Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, et al. PubMed PubMed Central Google Scholar Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. CAS PubMed PubMed Central Google Scholar Blau JE, Tella SH, Taylor SI, Rother KI. Google Scholar Ferrannini E, Muscelli E, Frascerra S, Baldi S, Mari A, Heise T, et al. CAS PubMed PubMed Central Google Scholar Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. CAS PubMed Google Scholar Inzucchi SE, Iliev H, Pfarr E, Zinman B. PubMed Google Scholar Potier L, Roussel R, Velho G, Saulnier PJ, Bumbu A, Matar O, et al. CAS PubMed Google Scholar Li X, Li T, Cheng Y, Lu Y, Xue M, Xu L, et al. PubMed Google Scholar Cheng L, Li YY, Hu W, Bai F, Hao HR, Yu WN, et al. CAS PubMed Google Scholar Milder TY, Stocker SL, Day RO, Greenfield JR. CAS PubMed Google Scholar Esquivel MA, Lansang MC. PubMed Google Scholar Singh-Franco D, Perez A, Harrington C. CAS PubMed Google Scholar Defronzo RA. CAS PubMed PubMed Central Google Scholar Nwose OM, Jones MR. PubMed PubMed Central Google Scholar Ooi CP, Loke SC. PubMed Google Scholar Saudek CD, Brick JC. PubMed PubMed Central Google Scholar Radin MS. PubMed Google Scholar Halimi S. CAS PubMed Google Scholar Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. PubMed Google Scholar Newton CA, Adeel S, Sadeghi-Yarandi S, Powell W, Migdal A, Smiley D, et al. PubMed Google Scholar Resnick HE, Heineman J, Stone R, Shorr RI. PubMed Google Scholar Dybicz SB, Thompson S, Molotsky S, Stuart B. PubMed Google Scholar Neuwahl SJ, Honeycutt AA, Poehler DC, Shrestha SS, Zhang P, Hoerger TJ. PubMed Google Scholar Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, et al. PubMed PubMed Central Google Scholar Thomson FJ, Masson EA, Leeming JT, Boulton AJ. CAS PubMed Google Scholar Dorner B, Friedrich EK, Posthauer ME. PubMed Google Scholar Munshi MN, Florez H, Huang ES, Kalyani RR, Mupanomunda M, Pandya N, et al. CAS PubMed PubMed Central Google Scholar Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. PubMed Google Scholar Pandya N, Thompson S, Sambamoorthi U. Blood Sugar Glucose Blood sugar blood glucose control is critical to daily function. Muscles use sugar for energy every time we move, and as we age, two problems develop: 1 Insulin Sensitivity Young, healthy muscle and other tissues throughout the body are highly sensitive to insulin. Tips: So, what can you do? Many lifestyle strategies can prevent diabetes, including the following: 1 Exercise Regularly Research shows that even easy exercise increases insulin sensitivity in muscles and improves pancreas insulin production, which reduces your risk for many diseases including diabetes. How much exercise should I do? The American Heart Association recommends minutes per week of moderate aerobic exercise like brisk walking or 75 minutes of vigorous exercise jogging, cycling, etc. Does it matter when I exercise? While exercise any time of day is beneficial for blood glucose and triglycerides, some research suggests that the timing of exercise around a meal may be important. Aerobic exercise may have the most powerful effect when performed after a meal. This is likely because exercise slows the release of nutrients from the stomach and increases use of sugar by muscles. Interestingly, not only aerobic exercise but also resistance exercise — like lifting weights — can lower blood glucose and triglycerides following a meal. To sum up, both aerobic and resistance exercise following a meal would be good strategies to control your blood glucose and prevent diabetes. How hard should I exercise? Most research suggests that mild exercise such as brisk walking or lifting weights is enough to benefit insulin sensitivity and production — and the effect is immediate. This means that you need at least a little exercise nearly every day to reduce the risk of diabetes. More vigorous exercise will improve your heart health and muscle strength. However, you should be careful when performing vigorous exercise to avoid developing low blood sugar hypoglycemia. For the same reason that exercise is good for reducing blood sugar, there is a small chance that your blood sugar could drop too low with prolonged vigorous exercise. Adding a little sugar — such as a sports energy drink mix — to your water bottle is a good idea for preventing too much of a drop in your blood sugar. Get Email Updates. Want to receive the Center for Healthy Aging newsletter? Click the icon to subscribe and receive CHA updates. Recent Posts:. Innovative ways to support legal deserts in Colorado December 8, Overcoming ageism in healthcare October 25, |
0 thoughts on “Hyperglycemia and aging”